Tokyo, Sept. 16 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000062910) titled 'An observational study of sarcopenia risk assessment and glycemic management in patients aged 65 years or older patients with type 2 diabetes' on Sept. 16.
Study Type:
Observational
Primary Sponsor:
Institute - Sumitomo Pharma Co., Ltd.
Condition:
Condition - Type 2 diabetes mellitus
Classification by malignancy - Others
Genomic information - NO
Objective:
Narrative objectives1 - To prospectively examine glycemic management (HbA1c) over 48 weeks, as assessed by HbA1c, according to sarcopenia risk status using the finger-ring test in older patients with type 2 diabetes mellitus. In addition, the proportion and ch...